Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

506 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
From dinosaurs to DNA: a history of colorectal cancer.
Mulcahy HE, Hyland J, O'Donoghue DP. Mulcahy HE, et al. Int J Colorectal Dis. 2003 May;18(3):210-5. doi: 10.1007/s00384-002-0461-0. Epub 2002 Dec 14. Int J Colorectal Dis. 2003. PMID: 12673485
Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.
Sheehan KM, O'Donovan DG, Fitzmaurice G, O'Grady A, O'Donoghue DP, Sheahan K, Byrne MF, Conroy RM, Kay EW, Murray FE. Sheehan KM, et al. Eur J Gastroenterol Hepatol. 2003 Apr;15(4):375-80. doi: 10.1097/00042737-200304000-00007. Eur J Gastroenterol Hepatol. 2003. PMID: 12655257
Inhibition of dendritic cell maturation by the tumor microenvironment correlates with the survival of colorectal cancer patients following bevacizumab treatment.
Michielsen AJ, Noonan S, Martin P, Tosetto M, Marry J, Biniecka M, Maguire AA, Hyland JM, Sheahan KD, O'Donoghue DP, Mulcahy HE, Fennelly D, Ryan EJ, O'Sullivan JN. Michielsen AJ, et al. Mol Cancer Ther. 2012 Aug;11(8):1829-37. doi: 10.1158/1535-7163.MCT-12-0162. Epub 2012 Jun 6. Mol Cancer Ther. 2012. PMID: 22675042
506 results